HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intralesional interferon alfa-2b as neoadjuvant treatment for perianal extramammary Paget's disease.

AuthorsV Panasiti, U Bottoni, V Devirgiliis, M Mancini, M Rossi, M Curzio, S Calvieri
JournalJournal of the European Academy of Dermatology and Venereology : JEADV (J Eur Acad Dermatol Venereol) Vol. 22 Issue 4 Pg. 522-3 (Apr 2008) ISSN: 1468-3083 [Electronic] England
PMID18363931 (Publication Type: Case Reports, Letter)
Chemical References
  • Antineoplastic Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
Topics
  • Aged
  • Antineoplastic Agents (administration & dosage, therapeutic use)
  • Anus Neoplasms (drug therapy)
  • Humans
  • Injections, Intralesional
  • Interferon alpha-2
  • Interferon-alpha (administration & dosage, therapeutic use)
  • Male
  • Neoadjuvant Therapy
  • Paget Disease, Extramammary (drug therapy)
  • Recombinant Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: